Firms
Theme

ROKU

Roku, Inc. Class A · NASDAQ

News

10 latest

Zacks Investment Research

Roku (ROKU) Ascends While Market Falls: Some Facts to Note

Roku (ROKU) closed at $160.06, up 1.45%, outperforming the S&P 500's decline. The company has earned a Zacks Rank #1 (Strong Buy) rating with projected Q3 2026 EPS of $0.55 (up 243.75% YoY) and full-year revenue expected at $5.61 billion (up 18.46% YoY). However, the stock trades at a premium Forward P/E of 54.43 versus the industry average of 9.41.

Zacks Investment Research

Roku, Inc. (ROKU) Is a Trending Stock: Facts to Know Before Betting on It

Roku has been trending on Zacks.com's most searched stocks list. The company shows strong earnings growth with consensus estimates of $0.55 per share for the current quarter (+243.8% YoY) and $2.84 for the fiscal year (+381.4% YoY).

Zacks Investment Research

Roku (ROKU) Laps the Stock Market: Here's Why

Roku (ROKU) closed at $154.34, up 1.16%, outperforming the S&P 500. The company has a Zacks Rank #1 (Strong Buy) rating with forecasted EPS of $0.56 (up 250% YoY) and revenue of $1.41 billion (up 16.51% YoY).

Zacks Investment Research

Roku, Inc. (ROKU) is Attracting Investor Attention: Here is What You Should Know

Roku has attracted investor attention with a Zacks Rank #1 (Strong Buy) rating. The company shows strong earnings growth expectations (+381.4% for current fiscal year) and consistent revenue growth (+18.5% for current fiscal year). Despite beating consensus estimates in recent quarters, Roku trades at a premium valuation (F grade) compared to peers.

Zacks Investment Research

Are Consumer Discretionary Stocks Lagging Kontoor Brands (KTB) This Year?

Kontoor Brands (KTB) is outperforming the Consumer Discretionary sector year-to-date, with a return of 5.9% compared to the sector's average loss of 15.2%. The stock holds a Zacks Rank #2 (Buy) with improved analyst sentiment. Roku (ROKU) is also highlighted as a strong performer in the sector with a 40.5% year-to-date return and a Zacks Rank #1 (Strong Buy).

Mentions ROKU

Zacks Investment Research

The Zacks Analyst Blog Highlights Ross Stores, Roku, APA, Corcept Therapeutics and Halozyme Therapeutics

Zacks highlights five non-tech Nasdaq stocks with Zacks Rank #1 (Strong Buy) ratings positioned for Q4 gains. Ross Stores benefits from strong sales momentum and store expansion; Roku capitalizes on the shift from linear TV to streaming advertising; APA Corp offers favorable capital efficiency and long-term growth; Corcept Therapeutics sees strong demand for Korlym and new product launches; Halozyme benefits from collaboration royalties and milestone payments.

Zacks Investment Research

Buy 5 Top-Ranked Non-Tech Nasdaq Stocks to Maximize Q4 Gains

Despite the Nasdaq's tech-heavy composition, five non-tech Nasdaq-listed stocks with Zacks Rank #1 ratings are positioned for strong growth. Ross Stores plans 115 store openings with 13% Q2 sales growth, Roku's advertising revenue climbed 24.8%, APA Corp benefits from cost savings and long-term growth projects, Corcept Therapeutics sees strong drug demand with recent FDA approvals, and Halozyme generates royalties from pharma collaborations.

Zacks Investment Research

Zacks.com featured highlights Roku, Forum Energy, Calumet, Calumet and Shell

Zacks.com identified five stocks with strong efficiency ratios across receivables turnover, asset utilization, inventory turnover, and operating margin metrics. The selected companies—Roku, Forum Energy Technologies, Calumet, TechnipFMC, and Shell—were filtered from over 7,906 stocks based on their operational effectiveness and financial health indicators.

Zacks Investment Research

Buy 5 Growth Stocks to Boost Your Portfolio in Q4 After a Mixed Q3

Zacks Investment Research identifies five growth stocks with Zacks Rank #1 (Strong Buy) ratings expected to perform well in Q4 2026, supported by softer inflation, lower bond yields, and reduced crude oil prices. The picks include Quanta Services (infrastructure/AI data centers), FormFactor (semiconductor testing), Semtech (data center networking), Centene (healthcare services), and Roku (streaming advertising), all showing strong revenue and earnings growth projections.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $ROKU · 0 threads

Sign in to post on $ROKU

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev